TNF and inflammatory bowel disease: In another study of 173 IBD-associated colorectal cancer patients from 78 hospitals, anti-TNF therapy was associated with a significant protective effect against CRC development (OR, 0.09, 95% CI, 0.01–0.68, p = 0.02) (Baars et al., 2011).